Asciminib, a novel allosteric inhibitor of BCR‐ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance.
Saved in:
| Title: | Asciminib, a novel allosteric inhibitor of BCR‐ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance. |
|---|---|
| Authors: | Okamoto, Naoki1,2, Yagi, Kenta1,3 yagi.kenta@tokushima-u.ac.jp, Imawaka, Sayaka1, Takaoka, Mayu1, Aizawa, Fuka1,2, Niimura, Takahiro1,3, Goda, Mitsuhiro1,2, Miyata, Koji1, Kawada, Kei1,4, Izawa‐Ishizawa, Yuki1,5, Sakaguchi, Satoshi3,6, Ishizawa, Keisuke1,2,3 |
| Source: | Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20521707 |
|---|---|
| DOI: | 10.1002/prp2.1214 |
